Soluble Molecules as Biological Markers in Hodgkin's Disease

References

• Falini B., Pileri S., Pizzolo G., Dürkop H., Flenghi L., Stirpe F., Martelli M. F., Stein H. CDRO (Ki-l) molecule: a new cytokine receptor of tumor necrosis factor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1–14
   PubMed Web of Science ®Google Scholar
• Chilosi M., Pizzolo G. Biopathological features of Hodgkin's disease. Leukemia Lymphoma 1995; 16: 385–395
   PubMed Web of Science ®Google Scholar
• Gruss H. J., Herrmann F., Drexler H. G. Hodgkin's disease: a cytokine-producing tumor- a review. Crit. Rev. Oncogen. 1994; 5: 473–538
   PubMed Web of Science ®Google Scholar
• Haluska F. G., Brufsky A. M., Canellos G. P. The cellular biology of the Reed-Sternberg cell. J. Clin. Oncol. 1994; 84: 1005–1019
   Google Scholar
• Pizzolo G., Chilosi M., Vinante F., Dazzi F., Lestnni M., Perona G., Benedetti F., Todeschini G., Vincenzi C., Trentin L., Semenzato G. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br. J. Cancer 1987; 55: 427–428
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ip S. H., Thompson E., Wilimas J., Brown M., Dodge R. K., de Hoyos R. A., Berard C. W., Crist W. M. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease. Leukemia 1989; 3: 481–484
   PubMed Web of Science ®Google Scholar
• Gause A., Jung W., Shmits R., Tschiersch A., Scholz R., Pohl C., Hasenclever D., Diehl V., Pfreundschuh M. Soluble CD8, CD25, and CD30 antigens as prognostic-markers in patients with untreated Hodgkin's lymphoma. Ann. Oncol. 1992; 3: S49–S52, Suppl.
   PubMed Web of Science ®Google Scholar
• Ambrosetti A., Nadali G., Vinante F., Carlini S., Veneri D., Todeschini G., Morosato L., de Sabata D., Chilosi M., Maggi E., Parronchi P., Rornagnani S., Semenzato G., Perona G., Pizzolo G. Serum levels of soluble interleukin-2 receptor in Hodgkin's disease: relationship with clinical stage, tumor burden and treatment outcome. Cancer 1993; 72: 201–206
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Vinante F., Nadali G., Ricetti M. M., Morosato L., Marrocchella R., Vincenzi C., Semenzato G., Chilosi M. ICAM-l tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease. Br. J. Haematol. 1993; 84: 161–162
   PubMed Web of Science ®Google Scholar
• Pui C. H., Luo X., Evans W., Martin S., Rugg A., Wilimas J., Crist W. M., Hudson M. Serum intercellular adhesion molecule-l in childhood malignancy. Blood 1993; 82: 895–898
   PubMed Web of Science ®Google Scholar
• Nadali G., Vinante F., Rigo A., Tecchio C., Morosato L., Zanolin E., Perona G., Chilosi M., Pizzolo G. Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-l in Hodgkin's disease. Int. J. Clin. Lab. Reg. 1995; 25: 84–87
   PubMedGoogle Scholar
• Gruss H. J., Dolken G., Brach M. A., Mertelsmann R., Herrmann F. Serum levels of circulating ICAM-l are increased in Hodgkin's disease. Leukemia 1993; 7: 1245–1249
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ip S. H., Thompson E., Dodge A. K., Brown M., Wilimas J., Carrabis S., Kung P., Berard C. W., Crist W. M. Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome. Blood 1989; 73: 209–213
   PubMed Web of Science ®Google Scholar
• Gruss H. J., Dolken G., Brach M. A., Mertelsmann R., Herrmann F. The significance of serum levels of soluble 60 kDa receptors for tumor necrosis factor in patients with Hodgkin's disease. Leukemia 1993; 7: 1339–1343
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Vinante F., Chilosi M., Dallenhach F., Josimovic-Alasevic O., Diamantstein T., Stein H. Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. Br. J. Haematol. 1990; 75: 282–284
   PubMed Web of Science ®Google Scholar
• Cause A., Pohl C., Tschiersch A., Da Costa L., Jung W., Diehl V., Hasenclever D., Pfreundschuh M. —Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 1991; 77: 1983–1988
   PubMed Web of Science ®Google Scholar
• Nadali G., Vinante F., Ambrosetti A., Todeschini C., Veneri D., Zanotti R., Meneghini V., Ricetti M. M., Benedetti F., Vassanelli A., Perona G., Chilosi M., Menestrina F., Fiacchini M., Stein H., Pizzolo G. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol. 1994; 12: 793–797
   PubMed Web of Science ®Google Scholar
• Vinante F., Morosato L., Siviero F., Nadali G., Rigo A., Veneri D., de Sahata D., Vincenzi C., Chilosi M., Senienzato G., Pizzolo G. Soluble forms of p55-IL-2Ra, CD8 and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis. Haematologica 1994; 79: 413–419
   PubMed Web of Science ®Google Scholar
• Semenzato G., Pizzolo G., Zambello R. The interleukin-2/interleukin-2 receptor system: structural, immunological, and clinical features. Int. J. Clin. Lab. Res. 1992; 22: 133–142
   PubMedGoogle Scholar
• Rothlein R., Czajkowski M., O'Neill M. M., Marlin S. D., Mainolfi E., Meduzzi V. J. Induction of intercellular adhesion molecule-l on primary and continuous cell lines by pro-inflammatory cytokines. J. Immunol. 1988; 141: 1665–1669
   PubMed Web of Science ®Google Scholar
• Gearing A. J. H., Newman W. Circulating adhesion molecule in disease. Immunol. Today 1993; 14: 506–512
   PubMedGoogle Scholar
• Del Prete G., Maggi E., Pizzolo C., Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fashinating link. Immunol. Today 1995; 16: 76–80
   PubMedGoogle Scholar
• Romagnani S., Del Prete G., Maggi E., Chilosi M., Caligaris-Cappio F., Pizzolo G. CD30 and type-2 T-helper (Th2) responses. J. Leuk. Biol. 1995; 57: 726–730
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Romagnani S. CD30 molecule (Ki-l Ag): more than just a marker of CD30+ lymphoma. Haematologica 1995; 80: 357–366
   PubMed Web of Science ®Google Scholar